COMPAGNIE CHARGEURS INVEST (CRI.PA) Stock Fundamental Analysis
Europe - Euronext Paris - EPA:CRI - FR0000130692 - Common Stock
10.2 EUR
+0.02 (+0.2%)
Overall CRI gets a fundamental rating of 3 out of 10. We evaluated CRI against 16 industry peers in the Industrial Conglomerates industry. Both the profitability and financial health of CRI have multiple concerns. While showing a medium growth rate, CRI is valued expensive at the moment.
1. Profitability
1.1 Basic Checks
- CRI had positive earnings in the past year.
- In the past year CRI had a positive cash flow from operations.
- CRI had positive earnings in 4 of the past 5 years.
- In multiple years CRI reported negative operating cash flow during the last 5 years.
1.2 Ratios
- Looking at the Return On Assets, with a value of 0.28%, CRI is doing worse than 68.75% of the companies in the same industry.
- Looking at the Return On Equity, with a value of 1.03%, CRI is doing worse than 68.75% of the companies in the same industry.
- The Return On Invested Capital of CRI (5.14%) is better than 62.50% of its industry peers.
- Measured over the past 3 years, the Average Return On Invested Capital for CRI is in line with the industry average of 6.39%.
- The 3 year average ROIC (4.65%) for CRI is below the current ROIC(5.14%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.28% | ||
| ROE | 1.03% | ||
| ROIC | 5.14% |
ROA(3y)1.05%
ROA(5y)2.21%
ROE(3y)3.33%
ROE(5y)7.74%
ROIC(3y)4.65%
ROIC(5y)5.48%
1.3 Margins
- CRI has a Profit Margin of 0.37%. This is in the lower half of the industry: CRI underperforms 68.75% of its industry peers.
- CRI's Profit Margin has declined in the last couple of years.
- CRI has a Operating Margin of 6.41%. This is comparable to the rest of the industry: CRI outperforms 43.75% of its industry peers.
- In the last couple of years the Operating Margin of CRI has remained more or less at the same level.
- CRI has a Gross Margin of 28.51%. This is amonst the worse of the industry: CRI underperforms 81.25% of its industry peers.
- In the last couple of years the Gross Margin of CRI has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 6.41% | ||
| PM (TTM) | 0.37% | ||
| GM | 28.51% |
OM growth 3Y1.32%
OM growth 5Y1.18%
PM growth 3Y-37.78%
PM growth 5Y-16.13%
GM growth 3Y3.87%
GM growth 5Y1.23%
2. Health
2.1 Basic Checks
- CRI has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
- CRI has more shares outstanding than it did 1 year ago.
- CRI has more shares outstanding than it did 5 years ago.
- The debt/assets ratio for CRI has been reduced compared to a year ago.
2.2 Solvency
- Based on the Altman-Z score of 1.24, we must say that CRI is in the distress zone and has some risk of bankruptcy.
- The Altman-Z score of CRI (1.24) is worse than 81.25% of its industry peers.
- CRI has a debt to FCF ratio of 124.09. This is a negative value and a sign of low solvency as CRI would need 124.09 years to pay back of all of its debts.
- Looking at the Debt to FCF ratio, with a value of 124.09, CRI is doing worse than 68.75% of the companies in the same industry.
- A Debt/Equity ratio of 1.38 is on the high side and indicates that CRI has dependencies on debt financing.
- CRI's Debt to Equity ratio of 1.38 is on the low side compared to the rest of the industry. CRI is outperformed by 62.50% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.38 | ||
| Debt/FCF | 124.09 | ||
| Altman-Z | 1.24 |
ROIC/WACC0.8
WACC6.45%
2.3 Liquidity
- CRI has a Current Ratio of 1.30. This is a normal value and indicates that CRI is financially healthy and should not expect problems in meeting its short term obligations.
- The Current ratio of CRI (1.30) is worse than 87.50% of its industry peers.
- CRI has a Quick Ratio of 1.30. This is a bad value and indicates that CRI is not financially healthy enough and could expect problems in meeting its short term obligations.
- The Quick ratio of CRI (0.86) is worse than 62.50% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.3 | ||
| Quick Ratio | 0.86 |
3. Growth
3.1 Past
- CRI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 150.24%, which is quite impressive.
- Measured over the past years, CRI shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -14.59% on average per year.
- The Revenue has been growing slightly by 6.67% in the past year.
- Measured over the past years, CRI shows a small growth in Revenue. The Revenue has been growing by 3.10% on average per year.
EPS 1Y (TTM)150.24%
EPS 3Y-38.62%
EPS 5Y-14.59%
EPS Q2Q%-146%
Revenue 1Y (TTM)6.67%
Revenue growth 3Y-0.32%
Revenue growth 5Y3.1%
Sales Q2Q%-0.56%
3.2 Future
- Based on estimates for the next years, CRI will show a very strong growth in Earnings Per Share. The EPS will grow by 32.19% on average per year.
- The Revenue is expected to grow by 3.45% on average over the next years.
EPS Next Y-39.39%
EPS Next 2Y31.4%
EPS Next 3Y32.19%
EPS Next 5YN/A
Revenue Next Year2.38%
Revenue Next 2Y4.5%
Revenue Next 3Y3.45%
Revenue Next 5YN/A
3.3 Evolution
- When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
4. Valuation
4.1 Price/Earnings Ratio
- CRI is valuated quite expensively with a Price/Earnings ratio of 78.46.
- 68.75% of the companies in the same industry are cheaper than CRI, based on the Price/Earnings ratio.
- CRI's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 27.32.
- Based on the Price/Forward Earnings ratio of 13.38, the valuation of CRI can be described as correct.
- 75.00% of the companies in the same industry are more expensive than CRI, based on the Price/Forward Earnings ratio.
- The average S&P500 Price/Forward Earnings ratio is at 24.30. CRI is valued slightly cheaper when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 78.46 | ||
| Fwd PE | 13.38 |
4.2 Price Multiples
- Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CRI indicates a somewhat cheap valuation: CRI is cheaper than 75.00% of the companies listed in the same industry.
- 62.50% of the companies in the same industry are cheaper than CRI, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 74.67 | ||
| EV/EBITDA | 7.33 |
4.3 Compensation for Growth
- CRI's earnings are expected to grow with 32.19% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y31.4%
EPS Next 3Y32.19%
5. Dividend
5.1 Amount
- With a Yearly Dividend Yield of 1.28%, CRI has a reasonable but not impressive dividend return.
- Compared to an average industry Dividend Yield of 3.08, CRI is paying slightly less dividend.
- CRI's Dividend Yield is slightly below the S&P500 average, which is at 1.86.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.28% |
5.2 History
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
- CRI pays out 118.52% of its income as dividend. This is not a sustainable payout ratio.
DP118.52%
EPS Next 2Y31.4%
EPS Next 3Y32.19%
EPA:CRI (1/22/2026, 2:28:25 PM)
10.2
+0.02 (+0.2%)
Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryIndustrial Conglomerates
Earnings (Last)11-05 2025-11-05
Earnings (Next)02-11 2026-02-11/amc
Inst Owners4.68%
Inst Owner ChangeN/A
Ins Owners64.2%
Ins Owner ChangeN/A
Market Cap253.88M
Revenue(TTM)727.50M
Net Income(TTM)2.70M
Analysts74.29
Price Target11.56 (13.33%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.28% |
Yearly Dividend0
Dividend Growth(5Y)N/A
DP118.52%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-11.69%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-43.78%
EPS NY rev (3m)-58.68%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-2.5%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 78.46 | ||
| Fwd PE | 13.38 | ||
| P/S | 0.35 | ||
| P/FCF | 74.67 | ||
| P/OCF | 10.67 | ||
| P/B | 0.97 | ||
| P/tB | N/A | ||
| EV/EBITDA | 7.33 |
EPS(TTM)0.13
EY1.27%
EPS(NY)0.76
Fwd EY7.48%
FCF(TTM)0.14
FCFY1.34%
OCF(TTM)0.96
OCFY9.37%
SpS29.23
BVpS10.49
TBVpS-1.46
PEG (NY)N/A
PEG (5Y)N/A
Graham Number5.54
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.28% | ||
| ROE | 1.03% | ||
| ROCE | 7.02% | ||
| ROIC | 5.14% | ||
| ROICexc | 6.13% | ||
| ROICexgc | 13.12% | ||
| OM | 6.41% | ||
| PM (TTM) | 0.37% | ||
| GM | 28.51% | ||
| FCFM | 0.47% |
ROA(3y)1.05%
ROA(5y)2.21%
ROE(3y)3.33%
ROE(5y)7.74%
ROIC(3y)4.65%
ROIC(5y)5.48%
ROICexc(3y)5.7%
ROICexc(5y)7.48%
ROICexgc(3y)13.2%
ROICexgc(5y)17.03%
ROCE(3y)6.37%
ROCE(5y)7.53%
ROICexgc growth 3Y-6.3%
ROICexgc growth 5Y2.48%
ROICexc growth 3Y-7.54%
ROICexc growth 5Y-2.79%
OM growth 3Y1.32%
OM growth 5Y1.18%
PM growth 3Y-37.78%
PM growth 5Y-16.13%
GM growth 3Y3.87%
GM growth 5Y1.23%
F-Score7
Asset Turnover0.75
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.38 | ||
| Debt/FCF | 124.09 | ||
| Debt/EBITDA | 4.67 | ||
| Cap/Depr | 66.89% | ||
| Cap/Sales | 2.8% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 30.87% | ||
| Profit Quality | 125.93% | ||
| Current Ratio | 1.3 | ||
| Quick Ratio | 0.86 | ||
| Altman-Z | 1.24 |
F-Score7
WACC6.45%
ROIC/WACC0.8
Cap/Depr(3y)59.11%
Cap/Depr(5y)54.94%
Cap/Sales(3y)2.51%
Cap/Sales(5y)2.22%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)150.24%
EPS 3Y-38.62%
EPS 5Y-14.59%
EPS Q2Q%-146%
EPS Next Y-39.39%
EPS Next 2Y31.4%
EPS Next 3Y32.19%
EPS Next 5YN/A
Revenue 1Y (TTM)6.67%
Revenue growth 3Y-0.32%
Revenue growth 5Y3.1%
Sales Q2Q%-0.56%
Revenue Next Year2.38%
Revenue Next 2Y4.5%
Revenue Next 3Y3.45%
Revenue Next 5YN/A
EBIT growth 1Y57.43%
EBIT growth 3Y1%
EBIT growth 5Y4.32%
EBIT Next Year104.23%
EBIT Next 3Y38.23%
EBIT Next 5YN/A
FCF growth 1Y109.66%
FCF growth 3Y-17.92%
FCF growth 5Y170%
OCF growth 1Y244.24%
OCF growth 3Y-11.82%
OCF growth 5Y11.78%
COMPAGNIE CHARGEURS INVEST / CRI.PA FAQ
What is the ChartMill fundamental rating of COMPAGNIE CHARGEURS INVEST (CRI.PA) stock?
ChartMill assigns a fundamental rating of 3 / 10 to CRI.PA.
What is the valuation status of COMPAGNIE CHARGEURS INVEST (CRI.PA) stock?
ChartMill assigns a valuation rating of 3 / 10 to COMPAGNIE CHARGEURS INVEST (CRI.PA). This can be considered as Overvalued.
What is the profitability of CRI stock?
COMPAGNIE CHARGEURS INVEST (CRI.PA) has a profitability rating of 3 / 10.
Can you provide the PE and PB ratios for CRI stock?
The Price/Earnings (PE) ratio for COMPAGNIE CHARGEURS INVEST (CRI.PA) is 78.46 and the Price/Book (PB) ratio is 0.97.
How financially healthy is COMPAGNIE CHARGEURS INVEST?
The financial health rating of COMPAGNIE CHARGEURS INVEST (CRI.PA) is 1 / 10.